1. Home
  2. APYX vs CRBU Comparison

APYX vs CRBU Comparison

Compare APYX & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$4.58

Market Cap

169.6M

Sector

Health Care

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.93

Market Cap

192.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
CRBU
Founded
1982
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.6M
192.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
APYX
CRBU
Price
$4.58
$1.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$6.50
$10.75
AVG Volume (30 Days)
195.4K
1.8M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
3.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.93
$1.63
Revenue Next Year
$11.01
$10.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.59
$1.04
52 Week High
$4.50
$3.53

Technical Indicators

Market Signals
Indicator
APYX
CRBU
Relative Strength Index (RSI) 61.61 41.92
Support Level $3.39 $1.75
Resistance Level N/A $2.09
Average True Range (ATR) 0.32 0.17
MACD 0.03 -0.02
Stochastic Oscillator 81.48 7.98

Price Performance

Historical Comparison
APYX
CRBU

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: